TrustPoint.AI® Expands Leadership Team With Heads of Sales and Client Relationships
Appointments of Marie Johnson Wick and Lisa Alberti Support Growth Strategy in Construction Lending Sector SAN MATEO, Calif.–(BUSINESS WIRE)–TrustPoint... Read more.
Global Partners Declares Second-Quarter 2025 Cash Distribution of $0.7500 on Common Units
WALTHAM, Mass.–(BUSINESS WIRE)–Global Partners LP (NYSE: GLP) (“Global Partners” or the “Partnership”) today announced that the Board of Directors... Read more.
Schrödinger to Announce Second Quarter 2025 Financial Results on August 6
NEW YORK–(BUSINESS WIRE)–Schrödinger (Nasdaq: SDGR) will report its second quarter 2025 financial results on Wednesday, August 6, 2025, after the financial... Read more.
Johnson Fistel Investigates Fairness of Proposed Sale of Skechers to 3G Capital
SAN DIEGO–(BUSINESS WIRE)–Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Skechers U.S.A.,... Read more.
Global Virtual, Augmented and Mixed Reality Markets Report 2026-2036 | Comprehensive Profiles of 180+ Leading Companies Across the XR Ecosystem – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “The Global Virtual, Augmented and Mixed Reality Market 2026-2036” report has been added to ResearchAndMarkets.com’s... Read more.
Leveragen and Propeller Bio Announce Strategic Collaboration to Advance Antibody and Protein Therapeutics
BOSTON & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Leveragen, a Boston-based biotechnology company pioneering next-generation in vivo antibody... Read more.
Sierra Bancorp Declares Quarterly Cash Dividend
PORTERVILLE, Calif.–(BUSINESS WIRE)–Sierra Bancorp (Nasdaq: BSRR), parent of Bank of the Sierra, announced that its Board of Directors has declared a... Read more.
Omeros Corporation Announces Pricing of $22 Million Registered Direct Offering
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) (“Omeros” or the “Company”) announced that on July 24, 2025 it entered into a securities... Read more.
KalVista Pharmaceuticals Receives Positive CHMP Opinion for Sebetralstat for the Treatment of Hereditary Angioedema Attacks
If approved, sebetralstat will be the first and only oral on-demand treatment for HAE in the European Union (EU) European Commission decision expected by early October... Read more.
Strategy Announces Pricing of Initial Public Offering of STRC Stock
TYSONS CORNER, Va.–(BUSINESS WIRE)–Strategy™ (Nasdaq: MSTR/STRK/STRF/STRD) today announced the pricing of its initial public offering on July 24, 2025... Read more.